Supporting equitable, evidence-based antibiotic use through national clinical decision support

UniServices brought researchers and agritech leaders together to align University of Auckland capability with industry needs, strengthen partnerships, and accelerate real-world agritech solutions.

UniServices joins the Booster Innovation Fund to accelerate Kiwi science spin-outs, strengthening pathways from university research to global, high-impact ventures backed by patient capital.

UniServices portfolio company, Luminoma uses laser photonics to deliver rapid, non-invasive skin cancer diagnosis - cutting biopsy time, speeding decisions, and showcasing University innovation.

UniServices showcased nine University of Auckland ventures at Auckland Startup Week 2025, highlighting innovation and research impact across Aotearoa’s growing startup ecosystem.

UniServices and the University of Auckland top SCOPR® 2024 for active spinouts, showcasing their strength in turning world-class research into successful ventures with real-world impact.

University of Auckland research shows Auckland’s high Strep A infection rates and diverse population make it an ideal location for developing and testing a Strep A vaccine to prevent rheumatic fever.

UniServices-supported mRNA staph vaccine named a flagship project by the NZ RNA Platform.

Mike Roger, Strategic Growth Manager – Energy and Climate Innovations, UniServices

Celebrating 20 years of turning University research into world-changing ventures – from wireless EV charging to a thriving startup ecosystem that’s shaping New Zealand’s future.

Progress continues in the Government’s reforms to the science, innovation and technology system, with the announcement of a $231 million investment to establish the new ATPRO.

This inaugural event will connect international investors, entrepreneurs and startups to highlight the companies, ideas and people shaping Auckland’s reputation as a region for innovation.